Bioverge Monthly — July ‘18
Connecting the World to Startups Dedicated to Transforming Healthcare
Do Well by Doing Good.
Follow us on Twitter (@biovergehq) to keep up-to-date on the
latest trends in healthcare
Bioverge Welcomes
Xycrobe!
Microbes are everywhere. They live around us, on us and even in us. Xycrobe Therapeutics is developing innovations that take advantage of the ubiquitous nature of these microbes by turning them into vehicles for the delivery of biotherapeutics.
If you’re a founder of a health-tech startup and want to learn more about showcase opportunities, contact us here.
A Few of Our Favorite Stories
23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs (Forbes). GlaxoSmithKline has made a $300 million equity investment in 23andMe as part of a deal that pulls it close to the consumer genetics pioneer.
It’s Nearly Impossible to Diagnose Alzheimer’s Disease in Living People. Bill Gates Wants to Change That (Time). Bill Gates announced that he is committing more than $30 million to the Diagnostics Accelerator, a project that will focus on creating new strategies for diagnosing Alzheimer’s Disease.
Algorithm matches human cardiologists in detecting heart attacks (MIT Tech Review). Medical data tends to be messy and hard to annotate, which makes it hard for neural networks to learn from. But machine learning is beginning to make progress.
Inside the effort to print lungs and breathe life into them with stem cells (MIT Tech Review). The 3-D-printing project is the latest in a series of high-wire engineering efforts launched by United’s CEO, Martine Rothblatt, a onetime aerospace entrepreneur (she was the founding CEO of Sirius Satellite Radio) who changed careers in the 1990s after her daughter developed a rare lung disease.
New York Gives $25 Million to Breathe Life Into City’s Biotech Scene(WSJ). Startup accelerator IndieBio is looking to open a location, preferably in Manhattan, next year
Artificial Intelligence in Oncology: Fantasy or Reality? (LabTech.Edu). Artificial intelligence promises to use the power of data to solve some of the biggest problems of our time. But can it help us treat a disease as complex as cancer?
15 digital health mergers, acquisitions from Q2 2018 (Mobile Health News). This week, the acquisition everyone’s talking about is Amazon’s reported billion-dollar deal to buy pharmacy startup PillPack. But that deal was just the capstone on a busy quarter with 15 digital health mergers and acquisitions.
Michael J. Fox: Working towards cure for Parkinson’s “one of the great gifts of my life” (CBS). “I had a moment with somebody and they said, ‘Someday there’s gonna be a cure for Parkinson’s and it’s gonna be because of you.’ And to me this was the first time that it really struck me. And I didn’t — and not that I took it seriously, but I feel part of something that is much more special — if it happens it’s much more special than any movie or any TV show.”
Join The Network
Want to learn about the passionate people solving healthcare’s biggest challenges? The latest innovations impacting the future of our collective health? Do you want to help make an impact?
The Bioverge Team
- Sign up for our monthly newsletter
- Access our deal flow: Investors sign up for free!
- Are you a health-tech company raising a Seed or Series A? Apply to raise capital
- Follow us on Twitter @biovergehq
